141 related articles for article (PubMed ID: 27753035)
1. Digital PCR of Genomic Rearrangements for Monitoring Circulating Tumour DNA.
Do H; Cameron D; Molania R; Thapa B; Rivalland G; Mitchell PL; Murone C; John T; Papenfuss A; Dobrovic A
Adv Exp Med Biol; 2016; 924():139-146. PubMed ID: 27753035
[TBL] [Abstract][Full Text] [Related]
2. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples.
Ishii H; Azuma K; Sakai K; Kawahara A; Yamada K; Tokito T; Okamoto I; Nishio K; Hoshino T
Oncotarget; 2015 Oct; 6(31):30850-8. PubMed ID: 26334838
[TBL] [Abstract][Full Text] [Related]
3. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
[TBL] [Abstract][Full Text] [Related]
4. Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell-Free DNA from Patients with Advanced Non-Small Cell Lung Cancer.
Zhu G; Ye X; Dong Z; Lu YC; Sun Y; Liu Y; McCormack R; Gu Y; Liu X
J Mol Diagn; 2015 May; 17(3):265-72. PubMed ID: 25769900
[TBL] [Abstract][Full Text] [Related]
5. Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance.
Zheng D; Ye X; Zhang MZ; Sun Y; Wang JY; Ni J; Zhang HP; Zhang L; Luo J; Zhang J; Tang L; Su B; Chen G; Zhu G; Gu Y; Xu JF
Sci Rep; 2016 Feb; 6():20913. PubMed ID: 26867973
[TBL] [Abstract][Full Text] [Related]
6. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.
Pereira E; Camacho-Vanegas O; Anand S; Sebra R; Catalina Camacho S; Garnar-Wortzel L; Nair N; Moshier E; Wooten M; Uzilov A; Chen R; Prasad-Hayes M; Zakashansky K; Beddoe AM; Schadt E; Dottino P; Martignetti JA
PLoS One; 2015; 10(12):e0145754. PubMed ID: 26717006
[TBL] [Abstract][Full Text] [Related]
7. Next generation mapping reveals novel large genomic rearrangements in prostate cancer.
Jaratlerdsiri W; Chan EKF; Petersen DC; Yang C; Croucher PI; Bornman MSR; Sheth P; Hayes VM
Oncotarget; 2017 Apr; 8(14):23588-23602. PubMed ID: 28423598
[TBL] [Abstract][Full Text] [Related]
8. Identification and Use of Personalized Genomic Markers for Monitoring Circulating Tumor DNA.
Chen Y; George AM; Olsson E; Saal LH
Methods Mol Biol; 2018; 1768():303-322. PubMed ID: 29717450
[TBL] [Abstract][Full Text] [Related]
9. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
[TBL] [Abstract][Full Text] [Related]
10. Application of a highly sensitive detection system for epidermal growth factor receptor mutations in plasma DNA.
Nakamura T; Sueoka-Aragane N; Iwanaga K; Sato A; Komiya K; Kobayashi N; Hayashi S; Hosomi T; Hirai M; Sueoka E; Kimura S
J Thorac Oncol; 2012 Sep; 7(9):1369-81. PubMed ID: 22858585
[TBL] [Abstract][Full Text] [Related]
11. Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers.
Harris FR; Kovtun IV; Smadbeck J; Multinu F; Jatoi A; Kosari F; Kalli KR; Murphy SJ; Halling GC; Johnson SH; Liu MC; Mariani A; Vasmatzis G
Sci Rep; 2016 Jul; 6():29831. PubMed ID: 27436510
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of cell-free circulating tumor DNA testing for lung cancer.
Santarpia M; Karachaliou N; González-Cao M; Altavilla G; Giovannetti E; Rosell R
Biomark Med; 2016; 10(4):417-30. PubMed ID: 26974841
[TBL] [Abstract][Full Text] [Related]
14. EGFR array: uses in the detection of plasma EGFR mutations in non-small cell lung cancer patients.
Yam I; Lam DC; Chan K; Chung-Man Ho J; Ip M; Lam WK; Chan TK; Chan V
J Thorac Oncol; 2012 Jul; 7(7):1131-40. PubMed ID: 22610259
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma.
Calapre L; Warburton L; Millward M; Ziman M; Gray ES
Cancer Lett; 2017 Sep; 404():62-69. PubMed ID: 28687355
[TBL] [Abstract][Full Text] [Related]
16. The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring.
Openshaw MR; Page K; Fernandez-Garcia D; Guttery D; Shaw JA
Expert Rev Mol Diagn; 2016 Jul; 16(7):751-5. PubMed ID: 27144417
[TBL] [Abstract][Full Text] [Related]
17. Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer.
Murphy SJ; Aubry MC; Harris FR; Halling GC; Johnson SH; Terra S; Drucker TM; Asiedu MK; Kipp BR; Yi ES; Peikert T; Yang P; Vasmatzis G; Wigle DA
J Clin Oncol; 2014 Dec; 32(36):4050-8. PubMed ID: 25385739
[TBL] [Abstract][Full Text] [Related]
18. Cell-free circulating tumour DNA as a liquid biopsy in breast cancer.
De Mattos-Arruda L; Caldas C
Mol Oncol; 2016 Mar; 10(3):464-74. PubMed ID: 26776681
[TBL] [Abstract][Full Text] [Related]
19. Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.
Tsao SC; Weiss J; Hudson C; Christophi C; Cebon J; Behren A; Dobrovic A
Sci Rep; 2015 Jun; 5():11198. PubMed ID: 26095797
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells and DNA for real-time EGFR detection and monitoring of non-small-cell lung cancer.
He J; Tan W; Ma J
Future Oncol; 2017 Apr; 13(9):787-797. PubMed ID: 28073294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
